RESILIENCE helps you survive cancer with a strong heart

Jacques Monod Hospital joins the RESILIENCE project

We are happy to share that our RESILIENCE project keeps on growing! Jacques Monod Hospital, part of the Le Havre Hospital Group and a reference hospital in the Seine Estuary Territory in France with a comprehensive range of care, joined RESILIENCE in November.

At our meeting we talked about the project with Christophe Fruit, coordinator at the center with the aim of starting the recruitment at the Hospital in the coming weeks. We shared with him the work we do on RESILIENCE at European level to improve the lives of people undergoing cancer treatment, as we practice a novel healthcare intervention that reduces potential cardiac malfunctioning caused by the cancer treatment while undergoing chemotherapy or after it has ended.

Jacques Monod Hospital includes:

  • Short-stay adult medicine along with surgery units
  • The women, mothers and children pavilion, which includes pediatrics and gynecology-obstetrics services
  • Adult and child emergency services
  • The hospital’s logistics area

The Le Havre Hospital Group has more than 1,500 beds and places spread across different sites: Flaubert Hospital, Jacques Monod Hospital, Pierre Janet Hospital and the “Mary Thieullent” Institute of Paramedical Training. It cooperates on numerous missions with the Rouen University Hospital Center to promote access to care and continuity of care for the population.

Logotipo Resilience

Are you a patient participating in RESILIENCE? Here you will find useful information about the details of your participation, activities specifically designed for you. You will also be able to contact RESILIENCE researchers.

In accordance with the provisions of Regulation (EU) 2016/679 on the protection of personal data of natural persons (GDPR), the personal information you have provided will be incorporated into the data processing systems of the Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.) for the purpose of attending your registration application in the restricted area for patients participating in the RESILIENCE study. The legal basis for processing your personal data for this purpose is your explicit consent. Your personal data will not be disclosed to any recipients other than those to whom you authorise or when required by law to do so. You may exercise your rights of access, right to rectification, to object, to erasure, to restriction of processing, data portability and not to be subject to automated individual decision-making. To exercise these rights, as well as to obtain additional information about the processing of your personal data, you can consult the following link Terms and Conditions